A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)
Clinical trial NCT00000775 · COMPLETED
Trial details
- NCT number
- NCT00000775
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.